Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Operating Margin (2017 - 2026)

Updated

Takeda Pharmaceutical's Operating Margin came in at 16.51% for the quarter ended Jun 30, 2026, down 0.17 percentage points from 16.68% a year earlier and unchanged from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Operating Margin (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Operating Margin of 5.83%, down 4.55 percentage points year-over-year; for the year ended Mar 31, 2026, it came in at 0.14%, down 7.34 percentage points from the prior year.

  • Operating Margin carries a five-year change of -15.79 percentage points (years ended Mar 2021 to Mar 2026).
  • Going back by year, Operating Margin was 7.48% in the year ended Mar 31, 2025 (+2.46 pp), 5.02% in the year ended Mar 31, 2024 (-7.16 pp), 12.18% in the year ended Mar 31, 2023 (-0.73 pp) and 12.91% in the year ended Mar 31, 2022 (-3.01 pp).
  • The five-year range for quarterly Operating Margin is -38.03% (the quarter ended Dec 31, 2025) to 25.56% (the quarter ended Mar 31, 2022).
  • Year-over-year, Operating Margin increased in four of the last eight quarters, with an average year-over-year change of -5.21 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in the quarter ended Jun 30, 2025 (a gain of 2.91 percentage points), and the weakest in the quarter ended Dec 31, 2025 (a drop of 30.92 percentage points).
  • Business Quant data shows TAK's Operating Margin at 16.51% (quarter ended Mar 31, 2026), -38.03% (quarter ended Dec 31, 2025) and 11.97% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 16.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.51%
Mar 31, 2026 16.51%
Dec 31, 2025 -38.03%
Sep 30, 2025 11.97%
Jun 30, 2025 16.68%
Mar 31, 2025 15.28%
Dec 31, 2024 -7.11%
Sep 30, 2024 11.83%
Jun 30, 2024 13.77%
Mar 31, 2024 13.96%
Dec 31, 2023 8.43%
Sep 30, 2023 12.51%
Jun 30, 2023 15.92%
Mar 31, 2023 15.93%
Dec 31, 2022 13.40%
Sep 30, 2022 10.42%
Jun 30, 2022 15.48%
Mar 31, 2022 25.56%
Jun 30, 2021 26.17%
Mar 31, 2021 32.27%
API Access

Takeda Pharmaceutical Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY